CompletedNot Applicable

Diagnostic Reliability of OCT Biomarkers for iERM

Austria136 participantsStarted 2021-01-11

Plain-language summary

Several optical coherence tomography (OCT) biomarkers with potential to influence postsurgical outcomes after vitrectomy with membrane peeling for idiopathic epiretinal membranes (iERM) have been described in single predictor analyses in the past. Aim of the study is to assess the reliability of diagnosis of OCT biomarkers and to calculate their impact on postsurgical visual acuity in a multiple regression analysis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a) presence of an iERM, * b) indication for membrane peeling, defined as significant loss of visual acuity and/or metamorphopsia due to the ERM, * c) pseudophakia at the final visit at 3 months after surgery, and * d) written informed consent for study participation. Exclusion Criteria: * macular edema caused by conditions other than ERM were excluded from the study.

What they're measuring

reliability of diagnosing OCT biomarkers

Timeframe: 1 week

Trial details

NCT IDNCT04997876

SponsorVienna Institute for Research in Ocular Surgery

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-08-05

View on ClinicalTrials.gov More Idiopathic Epiretinal Membranes trials